Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia

Summary

30 patients will randomly be selected and will be administered either reboxetine or a placebo. changes in cognition and behavior will be assessed by computer tests and scales during a six week study period.

Timeline

Start

2006-03

Primary completion

—

Completion

2006-11

Publications

• Background Schutz G, Berk M. Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study. Int Clin Psychopharmacol. 2001 Sep;16(5):275-8. doi: 10.1097/00004850-200109000-00004.

Drugs

Indications